Literature DB >> 19641071

Failure of the MicroScan WalkAway system to detect heteroresistance to carbapenems in a patient with Enterobacter aerogenes bacteremia.

N C Gordon1, D W Wareham.   

Abstract

We report the failure of the automated MicroScan WalkAway system to detect carbapenem heteroresistance in Enterobacter aerogenes. Carbapenem resistance has become an increasing concern in recent years, and robust surveillance is required to prevent dissemination of resistant strains. Reliance on automated systems may delay the detection of emerging resistance.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19641071      PMCID： PMC2738127          DOI： 10.1128/JCM.01033-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  13 in total

1.  Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.

Authors:  Jian Li; Craig R Rayner; Roger L Nation; Roxanne J Owen; Denis Spelman; Kar Eng Tan; Lisa Liolios
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Unstable vancomycin heteroresistance is common among clinical isolates of methiciliin-resistant Staphylococcus aureus.

Authors:  Nottasorn Plipat; Gilat Livni; Heidi Bertram; Richard B Thomson
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

3.  Accuracies of beta-lactam susceptibility test results for Pseudomonas aeruginosa with four automated systems (BD Phoenix, MicroScan WalkAway, Vitek, and Vitek 2).

Authors:  Stefan Juretschko; Vincent J Labombardi; Stephen A Lerner; Paul C Schreckenberger
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

4.  Evaluation of CHROMagar KPC for rapid detection of carbapenem-resistant Enterobacteriaceae.

Authors:  Zmira Samra; Judi Bahar; Liora Madar-Shapiro; Nazi Aziz; Sara Israel; Jihad Bishara
Journal:  J Clin Microbiol       Date:  2008-07-16       Impact factor: 5.948

5.  Characterization of clinical isolates of Pseudomonas aeruginosa heterogeneously resistant to carbapenems.

Authors:  Spyros Pournaras; Alexandros Ikonomidis; Antonios Markogiannakis; Nicholas Spanakis; Antonios N Maniatis; Athanassios Tsakris
Journal:  J Med Microbiol       Date:  2007-01       Impact factor: 2.472

6.  In vivo development of carbapenem resistance in clinical isolates of Enterobacter aerogenes producing multiple beta-lactamases.

Authors:  Ya-Gang Chen; Ying Zhang; Yun-Song Yu; Ting-Ting Qu; Ze-Qing Wei; Ping Shen; Lan-Juan Li
Journal:  Int J Antimicrob Agents       Date:  2008-06-16       Impact factor: 5.283

Review 7.  Does antibiotic selection impact patient outcome?

Authors:  Stephan Harbarth; Vandack Nobre; Didier Pittet
Journal:  Clin Infect Dis       Date:  2006-11-27       Impact factor: 9.079

8.  Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom.

Authors:  Neil Woodford; Jiancheng Zhang; Marina Warner; Mary E Kaufmann; Jorge Matos; Alan Macdonald; Daniel Brudney; David Sompolinsky; Shiri Navon-Venezia; David M Livermore
Journal:  J Antimicrob Chemother       Date:  2008-09-23       Impact factor: 5.790

9.  Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing.

Authors:  Fred C Tenover; Rajinder K Kalsi; Portia P Williams; Roberta B Carey; Sheila Stocker; David Lonsway; J Kamile Rasheed; James W Biddle; John E McGowan; Bruce Hanna
Journal:  Emerg Infect Dis       Date:  2006-08       Impact factor: 6.883

10.  Detecting imipenem resistance in Acinetobacter baumannii by automated systems (BD Phoenix, Microscan WalkAway, Vitek 2); high error rates with Microscan WalkAway.

Authors:  Canan Kulah; Elif Aktas; Fusun Comert; Nagihan Ozlu; Isin Akyar; Handan Ankarali
Journal:  BMC Infect Dis       Date:  2009-03-16       Impact factor: 3.090
View more
  6 in total

1.  Comparison of BD Phoenix, Vitek 2, and MicroScan automated systems for detection and inference of mechanisms responsible for carbapenem resistance in Enterobacteriaceae.

Authors:  Neil Woodford; Anne T Eastaway; Michael Ford; Alistair Leanord; Chloe Keane; Reinhard M Quayle; Jane A Steer; Jiancheng Zhang; David M Livermore
Journal:  J Clin Microbiol       Date:  2010-06-09       Impact factor: 5.948

Review 2.  Expert systems in clinical microbiology.

Authors:  Trevor Winstanley; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

Review 3.  Antimicrobial heteroresistance: an emerging field in need of clarity.

Authors:  Omar M El-Halfawy; Miguel A Valvano
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

4.  Research of the heteroresistance of Pseudomonas aeruginosa to imipenem.

Authors:  Shencong Mei; Yulu Gao; Changtai Zhu; Chunlei Dong; Yawen Chen
Journal:  Int J Clin Exp Med       Date:  2015-04-15

5.  Carbapenem Heteroresistance in VIM-1-producing Klebsiella pneumoniae isolates belonging to the same clone: consequences for routine susceptibility testing.

Authors:  M Tato; M Morosini; L García; S Albertí; M T Coque; R Cantón
Journal:  J Clin Microbiol       Date:  2010-09-15       Impact factor: 5.948

Review 6.  Mechanisms and clinical relevance of bacterial heteroresistance.

Authors:  Dan I Andersson; Hervé Nicoloff; Karin Hjort
Journal:  Nat Rev Microbiol       Date:  2019-06-24       Impact factor: 60.633
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.